FDA 510(k)

RxSight® 側入式設備（63002）

K 號：K231838 · 2023-08-15

決定日期2023-08-15

產品代碼MSS

諮詢委員會此為醫療器材法規文本之翻譯。根據醫療法規翻譯政策，以下為繁體中文譯文：本文件概述適用於醫療器材之監管架構，包括美國食品藥物管理局（FDA）之上市前審查程序。第510(k)條途徑適用於與已合法上市器材（predicate device）實質等效之器材，而上市前核准（PMA）則為最高風險等級（Class III）器材所要求。臨床證據可能引用NCT編號之試驗登記，或PMID編號之同行評審文獻。所有產品名稱、公司名稱、識別碼及統一資源定位符（URL）均保留原文，以確保可追溯性及法規提交之完整性。

決定相當於

器材摘要

RxSight® Insertion Device (63002) is the device name listed in this FDA 510(k) record. The listed applicant is Rxsight, Inc.. It received FDA 510(k) clearance on 2023-08-15 under 510(k) number K231838. The device is classified under product code MSS. It was reviewed by the OP advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the RxSight® Insertion Device (63002)?

RxSight® Insertion Device (63002) is a medical device that received FDA 510(k) clearance on 2023-08-15. The listed applicant is Rxsight, Inc.. The 510(k) number is K231838.

When did RxSight® Insertion Device (63002) receive FDA 510(k) clearance?

RxSight® Insertion Device (63002) received FDA 510(k) clearance on 2023-08-15, under 510(k) number K231838.

Who is the listed applicant for RxSight® Insertion Device (63002)?

The FDA 510(k) record lists Rxsight, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for RxSight® Insertion Device (63002)?

The FDA product code for RxSight® Insertion Device (63002) is MSS.

其他以 Rxsight, Inc. 為申請人之記錄

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。

K261174RxSight® 側入式設備 K231466RxSight植入式設備 K201909RxSight 接觸鏡 K192926RxSight植入式設備 K181401RxSight植入式設備

相關器械（代碼：MSS）

相關紀錄係使用名稱、產品代碼或其他後設資料自動配對。配對結果並不構成已驗證的臨床、科學、企業或監管關係，請查閱連結的官方來源。

K261174RxSight® 側入式設備Rxsight, Inc.K252540ACCUJECT 注射器組 2.1-1P (LP604590)Medicel AG K242389EyeGility™ 預裝enVista IOLs植入器Bausch & Lomb, Incorporated K231106Accuject Refra Injector AR2900Medicel AG K231466RxSight植入式設備Rxsight, Inc.K212039CLAREON MONARCH IV IOL 選送系統Alcon Laboratories, Inc.

官方來源

在 FDA 資料庫中查看 →

資料來源為 FDA Open API。如需最新且權威的資訊，請始終參閱官方記錄。